KCNQ1OT1 and non-small cell lung carcinoma: However, another study on KCNQ1OT1 revealed that it was upregulated in patients with early-stage NSCLC with good prognosis, acting as an inhibitor of cell proliferation and tumor growth (Sun et al., 2018).